Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing

Elutia ( (ELUT) ) has provided an announcement.

On December 23, 2025, Elutia Inc. disclosed that it had received a notice from Nasdaq stating the company was no longer in compliance with the exchange’s $35 million minimum market value of listed securities requirement, after its market value had remained below that threshold for 30 consecutive business days, and that it also failed to meet Nasdaq’s minimum shareholder equity or net income standards. While Elutia’s stock continues to trade on the Nasdaq Capital Market, the company has until June 22, 2026 to restore its market value and until May 6, 2026 to regain compliance with the $1.00 minimum bid price rule first flagged in November 2025, with the potential for an additional 180-day extension; failure to meet these standards could ultimately lead to delisting, underscoring mounting listing-compliance pressures and uncertainty for shareholders as the company evaluates options such as a reverse stock split and potential appeals.

The most recent analyst rating on (ELUT) stock is a Hold with a $0.52 price target. To see the full list of analyst forecasts on Elutia stock, see the ELUT Stock Forecast page.

Spark’s Take on ELUT Stock

According to Spark, TipRanks’ AI Analyst, ELUT is a Neutral.

Elutia’s overall stock score reflects significant financial instability and bearish technical indicators. While strategic moves like the BioEnvelope sale offer some optimism, ongoing financial challenges and compliance risks weigh heavily on the stock’s outlook.

To see Spark’s full report on ELUT stock, click here.

More about Elutia

Elutia Inc. is a Delaware-incorporated company whose Class A common stock trades on the Nasdaq Capital Market under the symbol ELUT.

Average Trading Volume: 361,148

Technical Sentiment Signal: Sell

Current Market Cap: $29.58M

For an in-depth examination of ELUT stock, go to TipRanks’ Overview page.